Showing results (431-440 of 439) with videos related to

Sort By:
Pageof 44
You have reached the last page of results.This site can display upto 439 results.
Nature Medicine|December 5, 2022
Efficacy of empagliflozin in heart failure with preserved versus mid-range ejection fraction: a pre-specified analysis of EMPEROR-PreservedStefan D Anker, Javed Butler, Muhammad Shariq Usman, et al.
The New England Journal of Medicine|March 30, 2026
Left Atrial Appendage Closure or Anticoagulation for Atrial FibrillationShephal K Doshi, Saibal Kar, Devi G Nair, et al.
The New England Journal of Medicine|April 8, 2024
Apolipoprotein A1 Infusions and Cardiovascular Outcomes after Acute Myocardial InfarctionC Michael Gibson, Danielle Duffy, Serge Korjian, et al.
The New England Journal of Medicine|September 1, 2020
Cardiovascular and Renal Outcomes with Empagliflozin in Heart FailureMilton Packer, Stefan D Anker, Javed Butler, et al.
European Journal of Heart Failure|November 30, 2020
Baseline characteristics of patients with heart failure with preserved ejection fraction in the EMPEROR-Preserved trialStefan D Anker, Javed Butler, Gerasimos Filippatos, et al.
The New England Journal of Medicine|August 27, 2021
Empagliflozin in Heart Failure with a Preserved Ejection FractionStefan D Anker, Javed Butler, Gerasimos Filippatos, et al.
European Journal of Heart Failure|June 22, 2013
Clinical outcome endpoints in heart failure trials: a European Society of Cardiology Heart Failure Association consensus documentFaiez Zannad, Angeles Alonso Garcia, Stefan D Anker, et al.
European Journal of Heart Failure|March 28, 2017
New medicinal products for chronic heart failure: advances in clinical trial design and efficacy assessmentMartin R Cowie, Gerasimos S Filippatos, Maria de Los Angeles Alonso Garcia, et al.
The New England Journal of Medicine|August 26, 2022
Polypill Strategy in Secondary Cardiovascular PreventionJose M Castellano, Stuart J Pocock, Deepak L Bhatt, et al.
Pageof 44